Results 11 to 20 of about 884,619 (261)

Key elements in the quality assessment of a type 3 medication review [PDF]

Frontiers in Pharmacology, 2023
Background: Medication reviews are a structured evaluation of a patient’s pharmacotherapy with the aim of optimizing medicines use and improving health outcomes. This entails detecting drug related problems and recommending interventions. A high level of
Anneleen Robberechts, Anneleen Robberechts, Anneleen Robberechts, Melissa Michielsen, Stephane Steurbaut, Stephane Steurbaut, Guido R. Y. De Meyer, Hans De Loof   +7 more
doaj   +2 more sources

Effects of a community pharmacy-based structured medication review on drug-related problems in all-comers with polypharmacy: a randomized, controlled, double-blind, parallel-group trial [PDF]

Frontiers in Medicine
BackgroundMedication reviews may help to reduce the burdens of polypharmacy. A medication review type 2a is a structured evaluation of a patient’s pharmacotherapy based on medication history and patient information in a face-to-face interview.MethodsThis
Thorsten Bischof, Alexander Schmidt-Ilsinger, Magdalena Hoppel, Anton Kreuzer, Stefanie Briganser, Philipp Saiko, Susanne Ergott-Badawi, Raimund Podroschko, Stephan Moser, Michael Kossmeier, Bernd Jilma, Stefan Deibl, Christian Schoergenhofer   +12 more
doaj   +2 more sources

Medication Review: What’s in a Name and What Is It about? [PDF]

Pharmacy
Background: Medication review is a multifaceted service aimed at optimizing the use of medicines and enhancing the health outcomes of patients. Due to its complexity, it is crucial to clearly describe the service, its variants, and its components to ...
Anneleen Robberechts, Maja Brumer, Victoria Garcia-Cardenas, Niurka M. Dupotey, Stephane Steurbaut, Guido R. Y. De Meyer, Hans De Loof   +6 more
doaj   +2 more sources

Impact of a DSS-supported medication review on the safety of drug therapy and quality of life in patients with antithrombotic therapy [PDF]

Frontiers in Pharmacology
Polypharmacy is common among patients with antithrombotic medication, giving rise to concerns about Drug-Related Problems (DRPs). Therefore, these patients would benefit from a Medication Review (MR) along with pharmacist counselling to reduce the risks ...
Tanja Elnaz Hassanzadeh, Tanja Elnaz Hassanzadeh, Carina Hohmann, Carsten Culmsee   +3 more
doaj   +2 more sources

Use of the BRANT-MERQS scoring table for the quality assessment of type 3 medication review in patients with rheumatoid arthritis and those with type 2 diabetes mellitus [PDF]

Frontiers in Pharmacology
BackgroundA type 3 medication review (MR3) is a patient-centred medication service primarily provided by pharmacists and is presently employed routinely in several countries.
Anneleen Robberechts, Anneleen Robberechts, Anneleen Robberechts, Kaat Stas, Margot Puttemans, Laura Poppe, Stephane Steurbaut, Stephane Steurbaut, Guido R. Y. De Meyer, Guido R. Y. De Meyer, Hans De Loof, Hans De Loof   +11 more
doaj   +2 more sources

Use of an Electronic Medication Management Support System in Patients with Polypharmacy in General Practice: A Quantitative Process Evaluation of the AdAM Trial

Pharmaceuticals, 2022
Polypharmacy is associated with a risk of negative health outcomes. Potentially inappropriate medications, interactions resulting from contradicting medical guidelines, and inappropriate monitoring, all increase the risk.
Robin Brünn, Dorothea Lemke, Jale Basten, Petra Kellermann-Mühlhoff, Juliane Köberlein-Neu, Christiane Muth, Marjan van den Akker, on behalf of the AdAM Study Group   +7 more
doaj   +1 more source

Drug-Related Problems of Patients in Primary Health Care Institutions: A Systematic Review

Frontiers in Pharmacology, 2021
Introduction: Drug-related problems (DRPs) are not only detrimental to patients' physical health and quality of life but also lead to a serious waste of health care resources. The condition of DRPs might be more severe for patients in primary health care
Xiao-Feng Ni, Xiao-Feng Ni, Xiao-Feng Ni, Xiao-Feng Ni, Chun-Song Yang, Chun-Song Yang, Chun-Song Yang, Yu-Mei Bai, Zi-Xian Hu, Ling-Li Zhang, Ling-Li Zhang, Ling-Li Zhang, Ling-Li Zhang   +12 more
doaj   +1 more source

A Collaborative Deprescribing Intervention in a Subacute Medical Outpatient Clinic: A Pilot Randomized Controlled Trial

Metabolites, 2021
Medication deprescribing is essential to prevent inappropriate medication use in multimorbid patients. However, experience of deprescribing in Danish Subacute Medical Outpatient Clinics (SMOCs) is limited. The objective of our pilot study was to evaluate
Anissa Aharaz, Jens Henning Rasmussen, Helle Bach Ølgaard McNulty, Arne Cyron, Pia Keinicke Fabricius, Anne Kathrine Bengaard, Hayley Rose Constance Sejberg, Rikke Rie Løvig Simonsen, Charlotte Treldal, Morten Baltzer Houlind   +9 more
doaj   +1 more source

Recommendations for community pharmacy to improve access to medication advice for people from ethnic minority communities: A qualitative person‐centred codesign study

Health Expectations, 2022
Introduction Medicines‐centred consultations are vital to support medicine effectiveness and optimize health outcomes for patients. However, inequalities negatively impact ethnic minority populations when accessing medicines advice.
Anna Robinson, Nicola O'Brien, Laura Sile, Harpreet K. Guraya, Thorrun Govind, Vicki Harris, Guy Pilkington, Adam Todd, Andy Husband   +8 more
doaj   +1 more source

Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases

Frontiers in Pharmacology, 2022
Background: Patients with multiple sclerosis (MS) often undergo complex treatment regimens, resulting in an increased risk of polypharmacy and potential drug-drug interactions (pDDIs).
Michael Hecker, Niklas Frahm, Paula Bachmann, Jane Louisa Debus, Marie-Celine Haker, Pegah Mashhadiakbar, Silvan Elias Langhorst, Julia Baldt, Julia Baldt, Barbara Streckenbach, Barbara Streckenbach, Felicita Heidler, Uwe Klaus Zettl   +12 more
doaj   +1 more source